Éñ¾µ÷½Úµ°°×»ùÒò£¨neuregulin£©ÓÐÖúÓÚһЩÉñ¾Ï¸°ûµÄ¾øÔµ²ã½á¹¹Ðγɡ£À´×ÔŦԼ´óѧҽѧԺµÄJames SalzerºÍËûµÄͬÊÂÃÇÏòÎÒÃÇչʾÁ˸ûùÒòµÄ±í´ï»á´ÙʹËèÁ×Ö¬£¨myelin£©µÄºÏ³É¡£ÕâÖÖÖ¬ÖʲÄÁϰü¹ü×ÅһЩÉñ¾Ôª£¬²¢ÇÒ´ÙʹÕâЩÉñ¾Ôª±ÈÂã¶µÄÉñ¾ÔªÐźŴ«µÝËÙ¶ÈÔö¼Ó100±¶¡£Õâ¸öÑо¿Ð¡×éÑо¿ÁËСÊóµÄÉñ¾Ôª£¬ÕâЩÉñ¾ÔªÕý³£Çé¿öÏÂÊÇÓÐËèÇʵ쬵«Í¨¹ý»ùÒò¹¤³Ì¼¼ÊõÇóýÁËÉñ¾µ÷½Úµ°°×»ùÒò-1 IIIÐÍ»ùÒòµÄË«¿½±´£¬Ê¹µÃÕâЩϸ°ûÂã¶¡£Ñо¿Õß»¹·¢ÏÖһЩԱ¾Â㶵썼´Ã»ÓÐËèÇʵģ©Éñ¾ÔªÔÚ±í´ïÉñ¾µ÷½Úµ°°×»ùÒòÖ®ºó£¬»áÖØÐ»ñµÃ±£»¤²ã£¨protective layer£©¡£
(Fig: Schematic Summary of Abnormalities in Nerves with Altered NRG1 Type III Levels)
²Î¿´Ó¢ÎÄÔÎÄ£º
Neuregulin-1 Type III Determines the Ensheathment Fate of Axons
Volume 47, Issue 5 , 1 September 2005, Pages 681-694